[{"Assets_0_Q1_USD":154348000.0,"CommonStockSharesOutstanding_0_Q1_shares":64891218.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-44755000.0,"NetIncomeLoss_1_Q1_USD":-62134000.0,"StockholdersEquity_0_Q1_USD":60155000.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180807"}]